WHO Technical Report Series Series 988

Evaluation of Certain Veterinary Drug Residues in Food

Seventy-eighth Report of the Joint FAO/WHO Expert Committee on Food Additives

Paperback
February 2015
9789241209885
More details
  • Publisher
    World Health Organization
  • Published
    20th February 2015
  • ISBN 9789241209885
  • Language English
  • Pages 132 pp.
  • Size 6.25" x 9.4"
$48.00

This report represents the conclusions of a Joint FAO/WHO Expert Committee convened to evaluate the safety of residues of certain veterinary drugs in food and to recommend maximum levels for such residues in food.

The first part of the report considers general principles regarding the evaluation of residues of veterinary drugs within the terms of reference of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), including extrapolation of maximum residue limits (MRLs) to minor species, MRLs for veterinary drug residues in honey, MRLs relating to fish and fish species, dietary exposure assessment methodologies, the decision-tree approach to the evaluation of residues of veterinary drugs and guidance for JECFA experts.

Summaries follow of the Committee's evaluations of toxicological and residue data on a variety of veterinary drugs: two anthelminthic agents (derquantel, monepantel), three antiparasitic agents (emamectin benzoate, ivermectin, lasalocid sodium), one antibacterial, antifungal and anthelminthic agent (gentian violet) and two production aids (recombinant bovine somatotropins, zilpaterol hydrochloride). Annexed to the report is a summary of the Committee's recommendations on these drugs, including acceptable daily intakes (ADIs) and proposed MRLs.

World Health Organization

World Health Organization is a Specialized Agency of the United Nations, charged to act as the world's directing and coordinating authority on questions of human health. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends.